Skip to main content
Premium Trial:

Request an Annual Quote

N-of-One to Provide Clinical Interpretation Services for New England VA Oncology Program

NEW YORK (GenomeWeb) – N-of-One has been selected by the US Department of Veterans Affairs New England Veteran's Integrated Service Network to provide clinical interpretation services for its Precision Oncology Program, the company said today.

The program aims to test US veterans recently diagnosed with non-small cell lung cancer using next-generation sequencing panels, provide them individualized treatments, and allow them the opportuniity to participate in research.

N-of-One will work closely with Personalis and Personal Genome Diagnostics (PGDx), both of whom were tapped previously to support the program. PGDx provides targeted genomic testing services using its CancerSelect targeted gene panel, which detects alterations in 88 well-characterized genes that are associated with currently available or investigational treatments. Personalis was selected to perform clinical cancer testing and research services based on its ACE Extended Cancer Panel Test, which provides comprehensive genomic profiling of solid tumors and helps identify targeted treatment options.

For its part, N-of-One will handle the interpretation of the genomic data collected from testing. The company will also provide scientific and clinical evidence that supports possible therapeutic strategies relevant to each specific patient case, it said.

The Scan

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Target Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.